Churches nationwide issue plea for increased rates of African American organ donation

November 04, 2004

Washington, D.C., November 4, 2004 -- African American churches and black transplant surgeons nationwide will take part in the Linkages to Life: Organ, Tissue, and Bone Marrow Donation Awareness Program on November 14, with hopes of saving thousands of African Americans waiting for a transplant. The day coincides with the National Donor Sabbath declared by the U.S. Department of Health and Human Services. Linkages to Life is sponsored by The Links, Incorporated and Roche.

Of the more than 87,000 people on the nation's growing transplant waiting list, more than 25 percent of them are black. African Americans as a group have a greater-than-average need for organ and tissue transplantation because of the relatively high incidence in this population of certain medical conditions that can cause permanent organ damage, such as high blood pressure, diabetes, heart disease and kidney disorders. Some experts believe patients fare better when both donor and recipient are from the same racial or ethnic group.

"The organ shortage in this country is a medical crisis, especially in the black community, where the need is greatest. Certainly, increased rates of African American organ donation can help ease this crisis by creating the opportunity for more transplants," said Velma Scantlebury, M.D., director of transplantation services at the University of South Alabama in Mobile and a member of The Links, Incorporated. "I am proud to join my Link sisters and fellow surgeons in this initiative to let people know what is happening in our community."

Linkages to Life is an ongoing, church-based program designed to demystify organ, tissue and bone marrow donation, emphasizing the critical need in the African American community. This year's initiative is the largest ever, with participating churches urging congregations to strongly consider organ donation.

"Seven years on dialysis took a serious toll on my life. I waited so long, I quit waiting," said recent kidney transplant recipient Joann C. DuBose, also of Mobile, Ala. "Today, I am alive and healthy with a new kidney, thanks to someone else's generosity. If more people would consider donation, everyone in need could have this wonderful gift of life."

Linkages to Life events, usually held during church services, feature local organ donors, recipients and transplant medical professionals who share their stories to dispel myths about transplantation. Speakers also encourage attendees to fill out organ donor cards and discuss with their families the decision to donate.

"We're working hard to dispel myths about donation. People fear that donors don't receive proper treatment if they're sick, or that organs are distributed first to the rich or famous. It's not true," said Dr. Scantlebury. "We need to educate ourselves and our community about these issues. Because of advances in surgery and medical care after a transplant, more recipients than ever are living longer and healthier lives."
The Links, Incorporated is a not-for-profit organization, founded in Philadelphia, Pennsylvania in 1946. Our 10,000 members are women of African Ancestry, who are linked by 274 chapters around the globe. Programs of The Links, Incorporated are designed to enrich, sustain and ensure the identities, culture and economic survival of all people of African origin. Visit to learn more about The Links, Incorporated and Linkages to Life.

Roche is a leading pharmaceutical company in the field of transplantation, committed to further improving the long-term outcomes and quality of life for transplant patients. The company develops and markets innovative therapies that improve graft and post-transplant health. Visit for more information.

Contacts: Marietta English
The Links, Incorporated
248-877-7776 (cell)

Victoria Dent
The Links, Incorporated
716-481-5291 (cell)

Ketchum UK

Related Transplantation Articles from Brightsurf:

A revolutionary new treatment alternative to corneal transplantation
A new approach in ophthalmology that offers a revolutionary alternative to corneal transplantation has just been developed by researchers and clinicians in North America, Europe, and Oceania.

Fewer complications after organ transplantation
A large international study coordinated by University Hospital Regensburg and Charité - Universitätsmedizin Berlin has demonstrated the safety of new cell therapy approaches for use in kidney transplant recipients.

Elderly patients also benefit from kidney transplantation
So far, kidney transplantation has generally not been offered to elderly patients (>75 years) because of the perioperative risks.

New material will allow abandoning bone marrow transplantation
Scientists from the National University of Science and Technology 'MISIS' developed nanomaterial, which will be able to restore the internal structure of bones damaged due to osteoporosis and osteomyelitis.

Fewer medical tests -- timely listing for transplantation
Younger patients would benefit greatly from kidney transplantation. Their expected remaining lifetime may even be doubled by having a transplant.

Uterus transplantation -- ethically just as problematic as altruistic surrogacy
In 2014, the first child to have been gestated in a donated uterus was born.

Advancing transplantation: Hepatitis C-infected organs safe for transplantation when followed by antiviral treatment
Twenty patients at Penn Medicine have been cured of the hepatitis C virus (HCV) following lifesaving kidney transplants from deceased donors who were infected with the disease, according to a study published today in Annals of Internal Medicine.

Transplantation followed by antiviral therapy cured hepatitis C
Twenty patients who received kidneys transplanted from hepatitis C virus (HCV)-infected donors experienced HCV cure, good quality of life, and excellent renal function at one year.

The Journal of Heart and Lung Transplantation: 50 years of heart transplantation progress
This month marks the 50th anniversary of the world's first human heart transplant performed at Groote Schuur Hospital in Cape Town by South African surgeon, Christiaan Barnard.

Older donor lungs should be considered for transplantation
With a scarcity of lungs available for transplantation, the use of lungs from donors older than age 60 has been shown to achieve reasonable outcomes and should be considered as a viable option, according to research published online today in The Annals of Thoracic Surgery.

Read More: Transplantation News and Transplantation Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to